About Index Trending news
Analyze
Top 50 Pricing
Versartis, Inc.

Versartis, Inc.

Work at Versartis, Inc.? Add yourself to this profile

Versartis, Inc.

Versartis is a biotechnology company developing therapeutic proteins for the treatment of endocrine disorders.

Elsewhere

Alexa global traffic share

19 Feb 2014
$55,000,000
Venture capital (Series E)
08 Oct 2013
$20,000,000
Venture capital (Series D)
22 Jul 2013
$12,499,999
Venture capital (Series C)
16 Feb 2011
$21,000,000
Venture capital (Series B)
02 Jun 2009
$11,000,000
Venture capital (Series A)